By simplifying the supply chain
By using cloud technology
By providing straightforward solutions
You already have products in the market, but need to streamline operations.
You need to enter a new market or launch a product, but don’t have the setup to do so.
You need to rationalize your drug portfolio and explore divestment opportunities.
Managed by IP owner or our contract partners
Optional, depending on number of MAs held
Managed by IP owner or our contract partners
Optional, depending on number of MAs held
We make you an offer to buy the IP, and all services are transitioned
to Simple Pharma
We enable a hassle-free, rapid transition of operations and services.
Our web apps give you full visibility of everything that’s happening in the supply chain.
Our model is set up to allow you to retain ~90% of the sale value of the product.
Ferring Pharmaceuticals divests its full rights for Testavan® and Vitaros® to Simple Pharma.